Login to Your Account



Clinic Roundup


Monday, August 5, 2013
• Stemcells Inc., of Newark, Calif., presented data showing that two years after transplantation of its purified human neural stem cells into patients with Pelizaeus-Merzbacher disease (PMD), magnetic resonance imaging (MRI) suggested myelination was more pronounced than at one year post-transplantation.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription